Company Profiles

driven by the PitchBook Platform

Cranford Pharmaceuticals

Cranford Pharmaceuticals
2013 FOUNDED
PRIVATE STATUS
Senior Debt, Sec. LATEST DEAL TYPE
2 FINANCING ROUNDS
0 INVESTMENTS
Description

Owner and operator of a pharmaceutical company. The company offers a portfolio of products which includes branded propranolol pharmaceuticals that are marketed and sold under the Inderal brand name.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
11 Commerce Drive
Floor 1
Cranford, NJ 07016
United States

+1 (908) 372-1232

Cranford Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cranford Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Cranford Pharmaceuticals Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Cranford Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Cranford Pharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
Greg Ford President